Summary of INSPIRE PHARMACEUTICALS INC

Search - Finance Home - Yahoo! - Help

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

ISPH > SEC Filings for ISPH > Form 8-K on 21-Jan-2010

All Recent SEC Filings

Show all filings for INSPIRE PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INSPIRE PHARMACEUTICALS INC

21-Jan-2010

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On January 21, 2010, Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) issued a press release, attached to and made part of this report, announcing the results of its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

No. Description

99.1 Press release dated January 21, 2010.

Add ISPH to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for ISPH - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.